Effect of Oleanolic acid administration on hepatic AMPK, SIRT-1, IL-6 and NF-κB levels in experimental diabetes
Objectives Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5′–adenosine monophosphate (AMP)–activated protein kinas...
Saved in:
| Published in | Journal of diabetes and metabolic disorders Vol. 22; no. 1; pp. 581 - 590 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Cham
Springer International Publishing
01.06.2023
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Objectives
Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5′–adenosine monophosphate (AMP)–activated protein kinase (AMPK) / Sirtuin–1 (SIRT–1) activator and Interleukin 6 (IL–6) / Nuclear factor kappa B (NF–κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.
Methods
Twenty–eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.
Results
The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT–1 (47%) levels and higher hepatic NF–κB (53%) and IL–6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT–1 level, but tended to increase hepatic AMPK level and decrease hepatic NF–κB and IL–6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.
Conclusion
The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects. |
|---|---|
| AbstractList | Objectives
Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5′–adenosine monophosphate (AMP)–activated protein kinase (AMPK) / Sirtuin–1 (SIRT–1) activator and Interleukin 6 (IL–6) / Nuclear factor kappa B (NF–κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.
Methods
Twenty–eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.
Results
The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT–1 (47%) levels and higher hepatic NF–κB (53%) and IL–6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT–1 level, but tended to increase hepatic AMPK level and decrease hepatic NF–κB and IL–6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.
Conclusion
The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects. Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) / Sirtuin-1 (SIRT-1) activator and Interleukin 6 (IL-6) / Nuclear factor kappa B (NF-κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats. Twenty-eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days. The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT-1 (47%) levels and higher hepatic NF-κB (53%) and IL-6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT-1 level, but tended to increase hepatic AMPK level and decrease hepatic NF-κB and IL-6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats. The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects. ObjectivesDiabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5′–adenosine monophosphate (AMP)–activated protein kinase (AMPK) / Sirtuin–1 (SIRT–1) activator and Interleukin 6 (IL–6) / Nuclear factor kappa B (NF–κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.MethodsTwenty–eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.ResultsThe diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT–1 (47%) levels and higher hepatic NF–κB (53%) and IL–6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT–1 level, but tended to increase hepatic AMPK level and decrease hepatic NF–κB and IL–6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.ConclusionThe OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects. Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) / Sirtuin-1 (SIRT-1) activator and Interleukin 6 (IL-6) / Nuclear factor kappa B (NF-κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.ObjectivesDiabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) / Sirtuin-1 (SIRT-1) activator and Interleukin 6 (IL-6) / Nuclear factor kappa B (NF-κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.Twenty-eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.MethodsTwenty-eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT-1 (47%) levels and higher hepatic NF-κB (53%) and IL-6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT-1 level, but tended to increase hepatic AMPK level and decrease hepatic NF-κB and IL-6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.ResultsThe diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT-1 (47%) levels and higher hepatic NF-κB (53%) and IL-6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT-1 level, but tended to increase hepatic AMPK level and decrease hepatic NF-κB and IL-6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects.ConclusionThe OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects. |
| Author | Hayirli, Armagan Bolat, Ismail Iskender, Hatice Dokumacioglu, Eda Terim Kapakin, Kubra Asena Mokhtare, Behzat Yenice, Guler |
| Author_xml | – sequence: 1 givenname: Hatice orcidid: 0000-0002-8063-4972 surname: Iskender fullname: Iskender, Hatice email: haticeiskender2011@hotmail.com organization: Faculty of Healthy Sciences, Department of Nutrition and Dietetics, Artvin Coruh University – sequence: 2 givenname: Eda orcidid: 0000-0002-2223-1331 surname: Dokumacioglu fullname: Dokumacioglu, Eda organization: Faculty of Healthy Sciences, Department of Nutrition and Dietetics, Artvin Coruh University – sequence: 3 givenname: Kubra Asena orcidid: 0000-0002-1740-8657 surname: Terim Kapakin fullname: Terim Kapakin, Kubra Asena organization: Department of Pathology, Faculty of Veterinary Medicine, Ataturk University – sequence: 4 givenname: Ismail orcidid: 0000-0003-1398-7046 surname: Bolat fullname: Bolat, Ismail organization: Department of Pathology, Faculty of Veterinary Medicine, Ataturk University – sequence: 5 givenname: Behzat orcidid: 0000-0002-9075-7239 surname: Mokhtare fullname: Mokhtare, Behzat organization: Department of Pathology, Faculty of Veterinary Medicine, Ataturk University – sequence: 6 givenname: Armagan orcidid: 0000-0002-4446-0848 surname: Hayirli fullname: Hayirli, Armagan organization: Department of Animal Nutrition and Nutritional Disorders, Faculty of Veterinary Medicine, Ataturk University – sequence: 7 givenname: Guler orcidid: 0000-0003-0819-8843 surname: Yenice fullname: Yenice, Guler organization: Department of Animal Nutrition and Nutritional Disorders, Faculty of Veterinary Medicine, Ataturk University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37255809$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kd9OFDEUxhuDEURewAvTxBsvqPbvdObKIAHduIpRvG667Rko6bbjdJasr-ZD-EwWFhS5oGnak_T7vvx6zlO0lXIChJ4z-ppRqt8USTmlhHJOKGO6JetHaIdzxUijWrZ1p95Ge6Vc0Lq0blvWPEHbQnOlWtrtoOGo78FNOPf4JIJNOQaHrQseW78MKZRptFPICdd9DkOtHT749OXjPv42-3pK2D6ezUmDbfL48zH5_esdjnAJseCQMKwHGMMS0mQj9sEuYILyDD3ubSywd3Pvou_HR6eHH8j85P3s8GBOnNRqqqf0FpzrhOsBvFhQ23AlOBVMS6d6V58o6AaEp13jW-kks7RhvuOdb6wXu-jtJndYLZbgXaUYbTRDBbLjT5NtMP-_pHBuzvKlYbWlSnJeE17dJIz5xwrKZJahOIjRJsirYnjLmZCc8a5KX96TXuTVmOr_jGCNaLnS8irwxV2kvyy306iCdiNwYy5lhN64MF23vxKGWNHM1ezNZvamgprr2Zt1tfJ71tv0B01iYypVnM5g_If9gOsPqkXA8w |
| CitedBy_id | crossref_primary_10_1080_21688370_2024_2386183 crossref_primary_10_1080_01480545_2024_2391868 crossref_primary_10_52973_rcfcv_e34388 |
| Cites_doi | 10.1111/jcmm.15725 10.1016/j.jep.2017.08.036 10.3389/fphys.2019.01607 10.18295/squmj.2016.16.02.002 10.1039/d0fo01860k 10.1002/ptr.3385 10.3892/mmr.2017.7594 10.1093/clinchem/34.3.497 10.1501/Vetfak_0000002539 10.1038/emm.2016.16 10.1002/ptr.6821 10.1001/jama.286.3.327 10.12998/wjcc.v8.i10.1767 10.1002/mnfr.201300861 10.3892/ijmm.2017.3357 10.1038/nrm3311 10.1631/jzus.B1500291 10.1016/j.biopha.2018.02.115 10.1007/s10787-016-0275-2 10.31590/ejosat.676335 10.1038/emm.2016.81 10.1021/acs.molpharmaceut.6b00129 10.1615/CritRevImmunol.2020033210 10.1196/annals.1375.027 10.1055/s-0029-1186102 10.1080/13813455.2018.1493609 10.1016/bs.ircmb.2017.07.007 10.1016/j.cellsig.2013.06.007 10.1074/jbc.M412357200 10.1111/jphp.12668 10.1080/13813455.2019.1637436 10.1016/j.freeradbiomed.2010.03.024 10.4093/dmj.2013.37.5.315 10.2174/1389450118666170123145357 10.1016/0076-6879(90)86134-h 10.1007/s10787-018-0458-0 10.5530/ijper.51.3s.66 10.1038/nature03354 10.31590/ejosat.762959 10.1186/s12986-021-00621-9 10.3390/ijms21113858 10.1016/j.jhep.2004.10.004 10.1371/journal.pone.0046364 10.1111/j.1872-034X.2012.01031.x 10.19082/1832 10.1210/en.2014-1619 10.1080/10520295.2021.1954691 10.1152/ajpendo.00745.2009 10.1074/jbc.M110.123620 10.1016/j.freeradbiomed.2010.02.025 10.4239/wjd.v6.i3.456 10.1038/s41581-020-0278-5 10.1016/j.phytochem.2011.12.022 10.1007/s11886-019-1107-y 10.1016/j.cbi.2010.03.028 10.3390/molecules22111915 10.1016/j.diabres.2019.107843 10.1155/2013/378790 10.1016/B978-0-12-816965-0.00005-6 10.1155/2014/360438 10.1155/2021/5570939 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Copyright BioMed Central 2023 |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: Copyright BioMed Central 2023 |
| DBID | AAYXX CITATION NPM K9. 7X8 5PM |
| DOI | 10.1007/s40200-022-01178-x |
| DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2251-6581 |
| EndPage | 590 |
| ExternalDocumentID | PMC10225422 37255809 10_1007_s40200_022_01178_x |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Artvin Çoruh Üniversitesi grantid: 2021.M84.02.04 funderid: http://dx.doi.org/10.13039/501100020561 – fundername: ; grantid: 2021.M84.02.04 |
| GroupedDBID | -A0 -EM 0R~ 2NT 3V. 406 5VS 7X7 8FI 8FJ AACDK AAHNG AAJBT AASML AATNV AAUYE ABAKF ABDZT ABECU ABFTV ABJNI ABKCH ABMQK ABSXP ABTEG ABTKH ABTMW ABUWG ACAOD ACDTI ACGFS ACHSB ACOKC ACPIV ACZOJ ADBBV ADINQ ADKNI ADRAZ ADURQ ADYFF AEFQL AEMSY AESKC AFBBN AFKRA AFQWF AGDGC AGJBK AGMZJ AGQEE AGRTI AHBYD AHSBF AHYZX AIAKS AIGIU AILAN AITGF AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AOIJS AXYYD BAWUL BENPR BFQNJ BPHCQ BVXVI C24 CCPQU CWDGH DIK DPUIP EBLON EBS EJD FIGPU FINBP FNLPD FSGXE FYUFA GGCAI GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW IKXTQ IPNFZ ITC IWAJR J-C JZLTJ KQ8 LLZTM M48 M~E NPVJJ NQJWS O9J OK1 PQQKQ PROAC PT4 RBZ RIG ROL RPM RSV SJYHP SMD SNE SNPRN SOHCF SOJ SRMVM SSLCW STPWE UKHRP UOJIU UTJUX ZMTXR AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ NPM K9. 7X8 5PM |
| ID | FETCH-LOGICAL-c475t-c44daecc93cfeed3b0a6253203174c5fccc90e76e3d096d84c41a061d929d6ad3 |
| IEDL.DBID | M48 |
| ISSN | 2251-6581 |
| IngestDate | Thu Aug 21 18:36:05 EDT 2025 Fri Jul 11 00:54:25 EDT 2025 Wed Aug 27 14:44:24 EDT 2025 Mon Jul 21 05:57:14 EDT 2025 Tue Jul 01 01:29:48 EDT 2025 Thu Apr 24 23:11:47 EDT 2025 Fri Feb 21 02:43:24 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | SIRT-1 AMPK Inflammation Diabetes Oleanolic acid |
| Language | English |
| License | The Author(s), under exclusive licence to Tehran University of Medical Sciences 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c475t-c44daecc93cfeed3b0a6253203174c5fccc90e76e3d096d84c41a061d929d6ad3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-1398-7046 0000-0003-0819-8843 0000-0002-1740-8657 0000-0002-2223-1331 0000-0002-8063-4972 0000-0002-4446-0848 0000-0002-9075-7239 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/10225422 |
| PMID | 37255809 |
| PQID | 3163825742 |
| PQPubID | 105772 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10225422 proquest_miscellaneous_2821342129 proquest_journals_3163825742 pubmed_primary_37255809 crossref_citationtrail_10_1007_s40200_022_01178_x crossref_primary_10_1007_s40200_022_01178_x springer_journals_10_1007_s40200_022_01178_x |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-06-01 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Cham |
| PublicationPlace_xml | – name: Cham – name: Switzerland – name: London |
| PublicationTitle | Journal of diabetes and metabolic disorders |
| PublicationTitleAbbrev | J Diabetes Metab Disord |
| PublicationTitleAlternate | J Diabetes Metab Disord |
| PublicationYear | 2023 |
| Publisher | Springer International Publishing Nature Publishing Group |
| Publisher_xml | – name: Springer International Publishing – name: Nature Publishing Group |
| References | Zhao, Liu, Song, Liu, Han, Yuan (CR25) 2017; 69 Sen (CR20) 2020; 8 Foss-Freitas, Foss, Donadi, Foss (CR57) 2006; 1079 CR36 CR35 Pollier, Goossens, Oleanolic acid (CR58) 2012; 77 CR34 Mitchell, Carmody (CR15) 2018; 335 CR33 CR31 Frescas, Valenti, Accili (CR9) 2005; 280 Iskender, Yenice, Dokumacioglu, Hayirli, Sevim, Dokumacioglu (CR14) 2020; 126 Kitada, Koya (CR10) 2013; 37 Ren, Zhang, Liu, Cheng, Yang, Cui (CR40) 2020; 24 Abedimanesh, Asghari, Mohammadnejad, Daneshvar, Rahmani, Shokoohi (CR48) 2021; 18 Kişmiroğlu, Cengiz, Yaman (CR7) 2020; 18 Terim–Kapakin, Gumus, Imik, Kapakin, Saglam (CR28) 2012; 59 CR2 Hasanvand, Amini-Khoei, Hadian, Abdollahi, Tavangar, Dehpour (CR43) 2016; 24 Gregorio, Colell, Morales, Marí (CR50) 2020; 21 Huang, Mei, Hu (CR17) 2017; 18 Kooti, Farokhipour, Asadzadeh, Ashtary-Larky, Asadi-Samani (CR32) 2016; 8 Ruderman, Xu, Nelson, Cacicedo, Saha, Lan (CR11) 2010; 298 Tanyıldız, Yıldırım, Uğur, Yaman (CR46) 2021; 21 Yang, Zhang, Pan, Feldser, Lainez, Miller (CR51) 2012; 7 Kauppinen, Suuronen, Ojala, Kaarniranta, Salminen (CR49) 2013; 25 Laszczyk (CR59) 2009; 75 Wang, Li, Wu, Liu, Hu, Liao (CR42) 2011; 25 Akbari, Hassan-Zadeh (CR13) 2018; 26 Esterbauer, Cheeseman (CR26) 1990; 186 Wang, Zhang, Qin, Yi, Yu, Chen (CR41) 2018; 41 Sun, Oberley, Li (CR27) 1988; 34 Tangvarasittichai (CR21) 2015; 6 Saha, Dey, Sarkar IDe Sarker (CR38) 2018; 210 Manna, Das, Ghosh, Sil (CR53) 2010; 48 Iskender, Dokumacioglu, Terim-Kapakin, Yenice, Mohtare, Bolat (CR24) 2021; 15 Zatterale, Longo, Naderi, Raciti, Desiderio, Miele (CR52) 2020; 10 Apaydin-Yildirim, Kordali, Terim-Kapakin, Yildirim, Aktas-Senocak, Altın (CR29) 2017; 18 Yang, Kahn, Shi, Xue (CR47) 2010; 285 Cole, Florez (CR3) 2020; 16 Kunnumakkara, Shabnam, Girisa, Harsha, Banik, Devi (CR16) 2020; 40 CR19 Anwer, Alkarbi, Hassan, Alshahrani, Khan (CR39) 2021; 127 Glovaci, Fan, Wong (CR1) 2019; 21 Camer, Yu, Szabo, Huang (CR61) 2014; 58 Jugran, Rawat, Devkota, Bhatt, Rawal (CR30) 2021; 35 Svistounov, Smedsrød (CR55) 2004; 41 Kim, Yang, Kim, Kim, Ha (CR6) 2016; 48 Hardie, Ross, Hawley (CR5) 2012; 13 Yu, Sun, Peng, Yu, Li, Jiang (CR18) 2016; 13 Jiang, Chen, Zhang, Zhang, Tan, Feng (CR12) 2015; 156 Jeon (CR45) 2016; 48 Masola, Oguntibeju, Oyenihi (CR37) 2018; 101 CR23 Pradhan, Manson, Rifai, Buring, Ridker (CR56) 2001; 286 Romagnoli, Gomez-Cabrera, Perrelli, Biasi, Pallardó, Sastre (CR54) 2010; 49 Ban, Cheng, Sun, Jiang, Guo (CR44) 2020; 11 Loria, Lonardo, Anania (CR4) 2013; 43 Yaman, Uyar, Celik, Alkan, Keles, Yener (CR62) 2017; 51 Mohamed, Nafizah, Zariyantey, Budin (CR22) 2016; 16 An, Hu, Wang, Cui, Wu, Ding (CR60) 2017; 16 Rodgers, Lerin, Haas, Gygi, Spiegelman (CR8) 2005; 434 X Jiang (1178_CR12) 2015; 156 1178_CR36 J Mohamed (1178_CR22) 2016; 16 X Wang (1178_CR42) 2011; 25 D Glovaci (1178_CR1) 2019; 21 T Anwer (1178_CR39) 2021; 127 Z Yang (1178_CR47) 2010; 285 AK Jugran (1178_CR30) 2021; 35 H Esterbauer (1178_CR26) 1990; 186 Y Sun (1178_CR27) 1988; 34 A Sen (1178_CR20) 2020; 8 M Kitada (1178_CR10) 2013; 37 N Abedimanesh (1178_CR48) 2021; 18 SM Jeon (1178_CR45) 2016; 48 B Apaydin-Yildirim (1178_CR29) 2017; 18 1178_CR31 P Loria (1178_CR4) 2013; 43 G Huang (1178_CR17) 2017; 18 1178_CR35 1178_CR34 1178_CR33 AD Pradhan (1178_CR56) 2001; 286 J Kim (1178_CR6) 2016; 48 1178_CR2 AB Kunnumakkara (1178_CR16) 2020; 40 KA Terim–Kapakin (1178_CR28) 2012; 59 Q An (1178_CR60) 2017; 16 F Zatterale (1178_CR52) 2020; 10 Q Ban (1178_CR44) 2020; 11 A Kauppinen (1178_CR49) 2013; 25 D Svistounov (1178_CR55) 2004; 41 H Zhao (1178_CR25) 2017; 69 JP Mitchell (1178_CR15) 2018; 335 J Pollier (1178_CR58) 2012; 77 T Yaman (1178_CR62) 2017; 51 H Iskender (1178_CR24) 2021; 15 H Yang (1178_CR51) 2012; 7 P Manna (1178_CR53) 2010; 48 BC Ren (1178_CR40) 2020; 24 NB Ruderman (1178_CR11) 2010; 298 W Kooti (1178_CR32) 2016; 8 JT Rodgers (1178_CR8) 2005; 434 1178_CR19 B Masola (1178_CR37) 2018; 101 S Tanyıldız (1178_CR46) 2021; 21 M Akbari (1178_CR13) 2018; 26 MR Saha (1178_CR38) 2018; 210 D Frescas (1178_CR9) 2005; 280 H Iskender (1178_CR14) 2020; 126 S Tangvarasittichai (1178_CR21) 2015; 6 DG Hardie (1178_CR5) 2012; 13 C Kişmiroğlu (1178_CR7) 2020; 18 M Romagnoli (1178_CR54) 2010; 49 MC Foss-Freitas (1178_CR57) 2006; 1079 E Gregorio (1178_CR50) 2020; 21 Z Yu (1178_CR18) 2016; 13 N Wang (1178_CR41) 2018; 41 MN Laszczyk (1178_CR59) 2009; 75 A Hasanvand (1178_CR43) 2016; 24 D Camer (1178_CR61) 2014; 58 JB Cole (1178_CR3) 2020; 16 1178_CR23 |
| References_xml | – volume: 24 start-page: 12355 issue: 21 year: 2020 end-page: 67 ident: CR40 article-title: Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways publication-title: J Cell Mol Med doi: 10.1111/jcmm.15725 – volume: 210 start-page: 275 year: 2018 end-page: 86 ident: CR38 article-title: Acacia nilotica leaf improves insulin resistance and hyperglycemia associated acute hepatic injury and nephrotoxicity by improving systemic antioxidant status in diabetic mice publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2017.08.036 – volume: 10 start-page: 1607 year: 2020 ident: CR52 article-title: Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes publication-title: Front Physiol doi: 10.3389/fphys.2019.01607 – volume: 16 start-page: e132-41 issue: 2 year: 2016 ident: CR22 article-title: Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation publication-title: Sultan Qaboos Univ Med J doi: 10.18295/squmj.2016.16.02.002 – volume: 11 start-page: 7696 issue: 9 year: 2020 end-page: 706 ident: CR44 article-title: Effect of feeding type 2 diabetes mellitus rats with synbiotic yogurt sweetened with monk fruit extract on serum lipid levels and hepatic AMPK (5′ adenosine monophosphate-activated protein kinase) signaling pathway publication-title: Food Funct doi: 10.1039/d0fo01860k – volume: 25 start-page: 1031 issue: 7 year: 2011 end-page: 40 ident: CR42 article-title: Antidiabetic effect of oleanolic acid: a promising use of a traditional pharmacological agent publication-title: Phytother Res doi: 10.1002/ptr.3385 – volume: 16 start-page: 8413 issue: 6 year: 2017 end-page: 9 ident: CR60 article-title: Oleanolic acid alleviates diabetic rat carotid artery injury through the inhibition of NLRP3 inflammasome signaling pathways publication-title: Mol Med Rep doi: 10.3892/mmr.2017.7594 – volume: 34 start-page: 497 year: 1988 end-page: 500 ident: CR27 article-title: A simple method for clinical assay of superoxide dismutase publication-title: Clin Chem doi: 10.1093/clinchem/34.3.497 – volume: 59 start-page: 279 year: 2012 end-page: 87 ident: CR28 article-title: Effects of ascorbic and α–lipoic acid on secretion of HSP–70 and apoptosis in liver and kidneys of broilers exposed to heat stress publication-title: Ankara Univ Vet J doi: 10.1501/Vetfak_0000002539 – ident: CR35 – volume: 48 start-page: e224 issue: 4 year: 2016 ident: CR6 article-title: AMPK activators: mechanisms of action and physiological activities publication-title: Exp Mol Med doi: 10.1038/emm.2016.16 – volume: 35 start-page: 223 issue: 1 year: 2021 end-page: 45 ident: CR30 article-title: Diabetes and plant-derived natural products: from ethnopharmacological approaches to their potential for modern drug discovery and development publication-title: Phytother Res doi: 10.1002/ptr.6821 – volume: 286 start-page: 327 issue: 3 year: 2001 end-page: 34 ident: CR56 article-title: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus publication-title: JAMA doi: 10.1001/jama.286.3.327 – volume: 8 start-page: 1767 issue: 10 year: 2020 end-page: 92 ident: CR20 article-title: Prophylactic and therapeutic roles of oleanolic acid and its derivatives in several diseases publication-title: World J Clin Cases doi: 10.12998/wjcc.v8.i10.1767 – volume: 58 start-page: 1750 year: 2014 end-page: 9 ident: CR61 article-title: The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.201300861 – volume: 41 start-page: 1409 issue: 3 year: 2018 end-page: 18 ident: CR41 article-title: Amelioration of streptozotocin induced pancreatic β cell damage by morin: involvement of the AMPK FOXO3 catalase signaling pathway publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.3357 – ident: CR19 – volume: 13 start-page: 251 issue: 4 year: 2012 ident: CR5 article-title: AMPK: a nutrient and energy sensor that maintains energy homeostasis publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3311 – volume: 18 start-page: 501 issue: 6 year: 2017 end-page: 11 ident: CR29 article-title: Effect of Helichrysum plicatum DC. Subsp, plicatum ethanol extract on gentamicin-induced nephrotoxicity in rats publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1500291 – volume: 101 start-page: 447 year: 2018 end-page: 57 ident: CR37 article-title: Centella asiatica ameliorates diabetes-induced stress in rat tissues via influences on antioxidants and inflammatory cytokines publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.02.115 – volume: 24 start-page: 207 issue: 5 year: 2016 end-page: 19 ident: CR43 article-title: Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy publication-title: Inflammopharmacology doi: 10.1007/s10787-016-0275-2 – volume: 18 start-page: 162 year: 2020 end-page: 70 ident: CR7 article-title: Biochemistry of AMPK: mechanisms of action and importance in the treatment of diabetes publication-title: Eur J Sci Techn doi: 10.31590/ejosat.676335 – volume: 48 start-page: e245 issue: 7 year: 2016 end-page: 5 ident: CR45 article-title: Regulation and function of AMPK in physiology and diseases publication-title: Exp Mol Med doi: 10.1038/emm.2016.81 – volume: 13 start-page: 1699 issue: 5 year: 2016 end-page: 710 ident: CR18 article-title: Pharmacokinetics in vitro and in vivo of two novel prodrugs of oleanolic acid in rats and its hepatoprotective effects against liver injury induced by CCl4 publication-title: Mol Pharmacol doi: 10.1021/acs.molpharmaceut.6b00129 – volume: 40 start-page: 1 issue: 1 year: 2020 end-page: 39 ident: CR16 article-title: Inflammation, NF-kappaB, and chronic diseases: how are they linked? publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.2020033210 – volume: 1079 start-page: 177 year: 2006 end-page: 80 ident: CR57 article-title: In vitro TNF-alpha and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control publication-title: Ann NY Acad Sci doi: 10.1196/annals.1375.027 – ident: CR36 – volume: 75 start-page: 1549 issue: 15 year: 2009 end-page: 60 ident: CR59 article-title: Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy publication-title: Planta Med doi: 10.1055/s-0029-1186102 – volume: 126 start-page: 89 issue: 1 year: 2020 end-page: 93 ident: CR14 article-title: Astaxanthin alleviates renal damage of rats on high fructose diet through modulating NFκB/SIRT1 pathway and mitigating oxidative stress publication-title: Arch Physiol Biochem doi: 10.1080/13813455.2018.1493609 – volume: 335 start-page: 41 year: 2018 end-page: 84 ident: CR15 article-title: NF-κB and the Transcriptional control of inflammation publication-title: Int Rev Cell Mol Biol doi: 10.1016/bs.ircmb.2017.07.007 – volume: 25 start-page: 1939 issue: 10 year: 2013 end-page: 48 ident: CR49 article-title: Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders publication-title: Cell Sign doi: 10.1016/j.cellsig.2013.06.007 – volume: 280 start-page: 20589 issue: 21 year: 2005 end-page: 95 ident: CR9 article-title: Nuclear trapping of the forkhead transcription factor FoxO1 via sirt-dependent deacetylation promotes expression of glucogenetic genes publication-title: J Biol Chem doi: 10.1074/jbc.M412357200 – volume: 69 start-page: 295 issue: 3 year: 2017 end-page: 304 ident: CR25 article-title: Oleanolic acid rejuvenates testicular function through attenuating germ cell DNA damage and apoptosis via deactivation of NF–κB, p53 and p38 signaling pathways publication-title: J Pharm Pharmacol doi: 10.1111/jphp.12668 – volume: 127 start-page: 304 issue: 4 year: 2021 end-page: 10 ident: CR39 article-title: Modulatory effect of zingerone against STZ-nicotinamide induced type-2 diabetes mellitus in rats publication-title: Arch Physiol Biochem doi: 10.1080/13813455.2019.1637436 – volume: 49 start-page: n171 issue: 2 year: 2010 end-page: 7 ident: CR54 article-title: Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.03.024 – ident: CR2 – volume: 37 start-page: 315 issue: 5 year: 2013 end-page: 25 ident: CR10 article-title: SIRT1 in type 2 diabetes: mechanisms and therapeutic potential publication-title: Diabetes Metab J doi: 10.4093/dmj.2013.37.5.315 – volume: 18 start-page: 1296 issue: 11 year: 2017 end-page: 300 ident: CR17 article-title: The antioxidant activities of natural polysaccharides publication-title: Curr Drug Targets doi: 10.2174/1389450118666170123145357 – ident: CR33 – volume: 186 start-page: 407 year: 1990 end-page: 21 ident: CR26 article-title: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hidroxynonenal publication-title: Methods Enzymol doi: 10.1016/0076-6879(90)86134-h – volume: 26 start-page: 685 issue: 3 year: 2018 end-page: 98 ident: CR13 article-title: IL-6 signalling pathways and the development of type 2 diabetes publication-title: Inflammopharmacology doi: 10.1007/s10787-018-0458-0 – volume: 51 start-page: 450 issue: 3 year: 2017 end-page: 7 ident: CR62 article-title: Histopathological and immunohistochemical study of antidiabetic effects of heracleum persicum extract in experimentally diabetic rats publication-title: IJPER doi: 10.5530/ijper.51.3s.66 – volume: 434 start-page: 113 issue: 7029 year: 2005 end-page: 8 ident: CR8 article-title: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 publication-title: Nature doi: 10.1038/nature03354 – volume: 21 start-page: 389 year: 2021 end-page: 401 ident: CR46 article-title: AMPK’s natural activators and relationships with diseases publication-title: Eur J Sci Technol doi: 10.31590/ejosat.762959 – volume: 18 start-page: 92 issue: 1 year: 2021 ident: CR48 article-title: The antidiabetic effects of betanin in streptozotocininduced diabetic rats through modulating AMPK/SIRT1/NFκB signaling pathway publication-title: Nutr Metab (Lond) doi: 10.1186/s12986-021-00621-9 – volume: 21 start-page: 3858 issue: 11 year: 2020 ident: CR50 article-title: Relevance of SIRT1-NF-kappaB Axis as therapeutic target to ameliorate inflammation in liver disease publication-title: Int J Mol Sci doi: 10.3390/ijms21113858 – volume: 41 start-page: 1038 year: 2004 end-page: 40 ident: CR55 article-title: Hepatic clearance of advanced glycation end products (AGEs): myth or truth? publication-title: J Hepatol doi: 10.1016/j.jhep.2004.10.004 – ident: CR23 – volume: 7 start-page: e46364 issue: 9 year: 2012 ident: CR51 article-title: SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity publication-title: PLoS ONE doi: 10.1371/journal.pone.0046364 – volume: 43 start-page: 51 issue: 1 year: 2013 end-page: 64 ident: CR4 article-title: Liver and diabetes. A vicious circle publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2012.01031.x – volume: 8 start-page: 1832 issue: 1 year: 2016 end-page: 42 ident: CR32 article-title: The role of medicinal plants in the treatment of diabetes: a systematic review publication-title: Electron Physician doi: 10.19082/1832 – volume: 156 start-page: 1156 issue: 3 year: 2015 end-page: 70 ident: CR12 article-title: The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling publication-title: Endocrinology doi: 10.1210/en.2014-1619 – ident: CR31 – volume: 15 start-page: 1 year: 2021 end-page: 8 ident: CR24 article-title: Effects of oleanolic acid on inflammation and metabolism in diabetic rats publication-title: Biotech Histochem doi: 10.1080/10520295.2021.1954691 – volume: 298 start-page: E751 issue: 4 year: 2010 end-page: 60 ident: CR11 article-title: AMPK and SIRT1: a long-standing partnership? publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00745.2009 – ident: CR34 – volume: 285 start-page: 19051 issue: 25 year: 2010 end-page: 9 ident: CR47 article-title: Macrophage α1 AMP-activated protein kinase (α1AMPK) antagonizes fatty acid-induced inflammation through SIRT1 publication-title: J Biol Chem doi: 10.1074/jbc.M110.123620 – volume: 48 start-page: 1465 issue: 11 year: 2010 end-page: 84 ident: CR53 article-title: Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: prophylactic role of arjunolic acid publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.02.025 – volume: 6 start-page: 456 issue: 3 year: 2015 end-page: 80 ident: CR21 article-title: Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus publication-title: World J Diabetes doi: 10.4239/wjd.v6.i3.456 – volume: 16 start-page: 377 issue: 7 year: 2020 end-page: 90 ident: CR3 article-title: Genetics of diabetes mellitus and diabetes complications publication-title: Nat Rev Nephrol doi: 10.1038/s41581-020-0278-5 – volume: 77 start-page: 10 year: 2012 end-page: 5 ident: CR58 publication-title: Phytochemistry doi: 10.1016/j.phytochem.2011.12.022 – volume: 21 start-page: 21 issue: 4 year: 2019 ident: CR1 article-title: Epidemiology of diabetes mellitus and cardiovascular disease publication-title: Curr Cardiol Rep doi: 10.1007/s11886-019-1107-y – volume: 48 start-page: e224 issue: 4 year: 2016 ident: 1178_CR6 publication-title: Exp Mol Med doi: 10.1038/emm.2016.16 – volume: 285 start-page: 19051 issue: 25 year: 2010 ident: 1178_CR47 publication-title: J Biol Chem doi: 10.1074/jbc.M110.123620 – volume: 41 start-page: 1038 year: 2004 ident: 1178_CR55 publication-title: J Hepatol doi: 10.1016/j.jhep.2004.10.004 – volume: 335 start-page: 41 year: 2018 ident: 1178_CR15 publication-title: Int Rev Cell Mol Biol doi: 10.1016/bs.ircmb.2017.07.007 – ident: 1178_CR34 doi: 10.1016/j.cbi.2010.03.028 – volume: 186 start-page: 407 year: 1990 ident: 1178_CR26 publication-title: Methods Enzymol doi: 10.1016/0076-6879(90)86134-h – volume: 37 start-page: 315 issue: 5 year: 2013 ident: 1178_CR10 publication-title: Diabetes Metab J doi: 10.4093/dmj.2013.37.5.315 – volume: 75 start-page: 1549 issue: 15 year: 2009 ident: 1178_CR59 publication-title: Planta Med doi: 10.1055/s-0029-1186102 – volume: 21 start-page: 389 year: 2021 ident: 1178_CR46 publication-title: Eur J Sci Technol doi: 10.31590/ejosat.762959 – volume: 26 start-page: 685 issue: 3 year: 2018 ident: 1178_CR13 publication-title: Inflammopharmacology doi: 10.1007/s10787-018-0458-0 – volume: 25 start-page: 1031 issue: 7 year: 2011 ident: 1178_CR42 publication-title: Phytother Res doi: 10.1002/ptr.3385 – volume: 35 start-page: 223 issue: 1 year: 2021 ident: 1178_CR30 publication-title: Phytother Res doi: 10.1002/ptr.6821 – volume: 15 start-page: 1 year: 2021 ident: 1178_CR24 publication-title: Biotech Histochem doi: 10.1080/10520295.2021.1954691 – volume: 16 start-page: 8413 issue: 6 year: 2017 ident: 1178_CR60 publication-title: Mol Med Rep doi: 10.3892/mmr.2017.7594 – volume: 286 start-page: 327 issue: 3 year: 2001 ident: 1178_CR56 publication-title: JAMA doi: 10.1001/jama.286.3.327 – volume: 21 start-page: 21 issue: 4 year: 2019 ident: 1178_CR1 publication-title: Curr Cardiol Rep doi: 10.1007/s11886-019-1107-y – volume: 6 start-page: 456 issue: 3 year: 2015 ident: 1178_CR21 publication-title: World J Diabetes doi: 10.4239/wjd.v6.i3.456 – volume: 59 start-page: 279 year: 2012 ident: 1178_CR28 publication-title: Ankara Univ Vet J doi: 10.1501/Vetfak_0000002539 – volume: 18 start-page: 92 issue: 1 year: 2021 ident: 1178_CR48 publication-title: Nutr Metab (Lond) doi: 10.1186/s12986-021-00621-9 – volume: 34 start-page: 497 year: 1988 ident: 1178_CR27 publication-title: Clin Chem doi: 10.1093/clinchem/34.3.497 – volume: 24 start-page: 207 issue: 5 year: 2016 ident: 1178_CR43 publication-title: Inflammopharmacology doi: 10.1007/s10787-016-0275-2 – volume: 49 start-page: n171 issue: 2 year: 2010 ident: 1178_CR54 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.03.024 – volume: 13 start-page: 1699 issue: 5 year: 2016 ident: 1178_CR18 publication-title: Mol Pharmacol doi: 10.1021/acs.molpharmaceut.6b00129 – volume: 16 start-page: e132-41 issue: 2 year: 2016 ident: 1178_CR22 publication-title: Sultan Qaboos Univ Med J doi: 10.18295/squmj.2016.16.02.002 – volume: 127 start-page: 304 issue: 4 year: 2021 ident: 1178_CR39 publication-title: Arch Physiol Biochem doi: 10.1080/13813455.2019.1637436 – ident: 1178_CR19 doi: 10.3390/molecules22111915 – ident: 1178_CR2 doi: 10.1016/j.diabres.2019.107843 – volume: 101 start-page: 447 year: 2018 ident: 1178_CR37 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.02.115 – ident: 1178_CR23 doi: 10.18295/squmj.2016.16.02.002 – volume: 16 start-page: 377 issue: 7 year: 2020 ident: 1178_CR3 publication-title: Nat Rev Nephrol doi: 10.1038/s41581-020-0278-5 – volume: 126 start-page: 89 issue: 1 year: 2020 ident: 1178_CR14 publication-title: Arch Physiol Biochem doi: 10.1080/13813455.2018.1493609 – volume: 7 start-page: e46364 issue: 9 year: 2012 ident: 1178_CR51 publication-title: PLoS ONE doi: 10.1371/journal.pone.0046364 – volume: 25 start-page: 1939 issue: 10 year: 2013 ident: 1178_CR49 publication-title: Cell Sign doi: 10.1016/j.cellsig.2013.06.007 – volume: 18 start-page: 1296 issue: 11 year: 2017 ident: 1178_CR17 publication-title: Curr Drug Targets doi: 10.2174/1389450118666170123145357 – volume: 8 start-page: 1767 issue: 10 year: 2020 ident: 1178_CR20 publication-title: World J Clin Cases doi: 10.12998/wjcc.v8.i10.1767 – volume: 298 start-page: E751 issue: 4 year: 2010 ident: 1178_CR11 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00745.2009 – volume: 1079 start-page: 177 year: 2006 ident: 1178_CR57 publication-title: Ann NY Acad Sci doi: 10.1196/annals.1375.027 – volume: 18 start-page: 162 year: 2020 ident: 1178_CR7 publication-title: Eur J Sci Techn doi: 10.31590/ejosat.676335 – ident: 1178_CR36 doi: 10.1155/2013/378790 – ident: 1178_CR31 doi: 10.1016/B978-0-12-816965-0.00005-6 – volume: 48 start-page: 1465 issue: 11 year: 2010 ident: 1178_CR53 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.02.025 – volume: 13 start-page: 251 issue: 4 year: 2012 ident: 1178_CR5 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm3311 – volume: 51 start-page: 450 issue: 3 year: 2017 ident: 1178_CR62 publication-title: IJPER doi: 10.5530/ijper.51.3s.66 – volume: 24 start-page: 12355 issue: 21 year: 2020 ident: 1178_CR40 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15725 – ident: 1178_CR35 doi: 10.1155/2014/360438 – volume: 210 start-page: 275 year: 2018 ident: 1178_CR38 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2017.08.036 – volume: 156 start-page: 1156 issue: 3 year: 2015 ident: 1178_CR12 publication-title: Endocrinology doi: 10.1210/en.2014-1619 – ident: 1178_CR33 doi: 10.1155/2021/5570939 – volume: 21 start-page: 3858 issue: 11 year: 2020 ident: 1178_CR50 publication-title: Int J Mol Sci doi: 10.3390/ijms21113858 – volume: 280 start-page: 20589 issue: 21 year: 2005 ident: 1178_CR9 publication-title: J Biol Chem doi: 10.1074/jbc.M412357200 – volume: 40 start-page: 1 issue: 1 year: 2020 ident: 1178_CR16 publication-title: Crit Rev Immunol doi: 10.1615/CritRevImmunol.2020033210 – volume: 69 start-page: 295 issue: 3 year: 2017 ident: 1178_CR25 publication-title: J Pharm Pharmacol doi: 10.1111/jphp.12668 – volume: 18 start-page: 501 issue: 6 year: 2017 ident: 1178_CR29 publication-title: J Zhejiang Univ Sci B doi: 10.1631/jzus.B1500291 – volume: 434 start-page: 113 issue: 7029 year: 2005 ident: 1178_CR8 publication-title: Nature doi: 10.1038/nature03354 – volume: 43 start-page: 51 issue: 1 year: 2013 ident: 1178_CR4 publication-title: Hepatol Res doi: 10.1111/j.1872-034X.2012.01031.x – volume: 48 start-page: e245 issue: 7 year: 2016 ident: 1178_CR45 publication-title: Exp Mol Med doi: 10.1038/emm.2016.81 – volume: 77 start-page: 10 year: 2012 ident: 1178_CR58 publication-title: Phytochemistry doi: 10.1016/j.phytochem.2011.12.022 – volume: 8 start-page: 1832 issue: 1 year: 2016 ident: 1178_CR32 publication-title: Electron Physician doi: 10.19082/1832 – volume: 41 start-page: 1409 issue: 3 year: 2018 ident: 1178_CR41 publication-title: Int J Mol Med doi: 10.3892/ijmm.2017.3357 – volume: 10 start-page: 1607 year: 2020 ident: 1178_CR52 publication-title: Front Physiol doi: 10.3389/fphys.2019.01607 – volume: 58 start-page: 1750 year: 2014 ident: 1178_CR61 publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.201300861 – volume: 11 start-page: 7696 issue: 9 year: 2020 ident: 1178_CR44 publication-title: Food Funct doi: 10.1039/d0fo01860k |
| SSID | ssj0000778816 |
| Score | 2.2775464 |
| Snippet | Objectives
Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic... Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA)... ObjectivesDiabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 581 |
| SubjectTerms | Diabetes Drinking water Endocrinology Health care Kinases Medicine Medicine & Public Health Metabolic Diseases Research Article |
| Title | Effect of Oleanolic acid administration on hepatic AMPK, SIRT-1, IL-6 and NF-κB levels in experimental diabetes |
| URI | https://link.springer.com/article/10.1007/s40200-022-01178-x https://www.ncbi.nlm.nih.gov/pubmed/37255809 https://www.proquest.com/docview/3163825742 https://www.proquest.com/docview/2821342129 https://pubmed.ncbi.nlm.nih.gov/PMC10225422 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bTtwwEB0hkBAviBbahlJkJN5YV0ns3B4qtFt1xW0X1LISb5FjO2KlVRbYRaK_1o_oNzGTW9lykaK82Ekcj-054xmfAdh3kzh3lat4ZhLBpVEhVyoLuJW-l4VR4pqc9jsGw_BoJE-ugqslaNId1R04e9G0o3xSo7vJ14fb34c44b-1x-DIBnI5xaUTw1nMEVOuoGaKaKIOarhfrswRkaeX-eZQrXNUvl59jubl16zBqogQc8cUrvhUbT3Dos9DKv_zq5bqqr8B6zXOZN1qYLyDJVu8h9VB7UnfhJuKtphNc3Y-saogemCm9NgwtUCny_C6thR2rVl3cHHaYb-Of15yr8OOz3jIVGHYsM___umxCYUfzdi4YE-zBrBmc3cLRv0fl9-PeJ19gWsZBXO8o-RQwInQOSpSkbkKbSXh4yoQSR3kGotcG4VWGDSDTCy19BSiA4OAy4TKiA-wXEwL-wlYjLDGJHFklER7MjDKR1ySSaO9MDOxkg54TeemuqYmpwwZk7QlVS5lk6Js0lI26YMDB-0zNxUxx5u1dxqZpc0YSwVhUVyypO_AXluM04t8Jqqw0_tZihapJ8hrnjjwsRJx-7lmbDgQLwi_rUDU3Yslxfi6pPAmOzuQPn6404yTf-16_Te2X23DZ1jzEX5VQWw7sDy_u7dfEC7Ns11Y6fZ7veFuORceAR4DDU4 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Oleanolic+acid+administration+on+hepatic+AMPK%2C+SIRT-1%2C+IL-6+and+NF-%CE%BAB+levels+in+experimental+diabetes&rft.jtitle=Journal+of+diabetes+and+metabolic+disorders&rft.au=Iskender%2C+Hatice&rft.au=Dokumacioglu%2C+Eda&rft.au=Terim+Kapakin%2C+Kubra+Asena&rft.au=Bolat%2C+Ismail&rft.date=2023-06-01&rft.issn=2251-6581&rft.eissn=2251-6581&rft.volume=22&rft.issue=1&rft.spage=581&rft_id=info:doi/10.1007%2Fs40200-022-01178-x&rft_id=info%3Apmid%2F37255809&rft.externalDocID=37255809 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2251-6581&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2251-6581&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2251-6581&client=summon |